Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

HVTN 505 is a preventative vaccine efficacy trial testing DNA followed by recombinant adenovirus serotype 5 (rAd5) in circumcised, Ad5-seronegative men and transgendered persons who have sex with men in the United States. Identified immune correlates of lower HIV-1 risk and a virus sieve analysis re...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Invest
Huvudupphovsmän: Neidich, Scott D., Fong, Youyi, Li, Shuying S., Geraghty, Daniel E., Williamson, Brian D., Young, William Chad, Goodman, Derrick, Seaton, Kelly E., Shen, Xiaoying, Sawant, Sheetal, Zhang, Lu, deCamp, Allan C., Blette, Bryan S., Shao, Mengshu, Yates, Nicole L., Feely, Frederick, Pyo, Chul-Woo, Ferrari, Guido, Frank, Ian, Karuna, Shelly T., Swann, Edith M., Mascola, John R., Graham, Barney S., Hammer, Scott M., Sobieszczyk, Magdalena E., Corey, Lawrence, Janes, Holly E., McElrath, M. Juliana, Gottardo, Raphael, Gilbert, Peter B., Tomaras, Georgia D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Clinical Investigation 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819135/
https://ncbi.nlm.nih.gov/pubmed/31589165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI126391
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk